Zimmer Biomet Holdings (ZBH) Cash from Investing Activities (2009 - 2026)

Zimmer Biomet Holdings' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$159.0 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 50.0% year-over-year to -$159.0 million; the TTM figure through Mar 2026 stood at -$2.0 billion (down 153.87% YoY), while the FY2025 annual figure was -$2.0 billion, down 122.46% from the prior year.
• Cash from Investing Activities was -$159.0 million for Q1 2026 at Zimmer Biomet Holdings, up from -$322.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$81.1 million in Q1 2022 to a low of -$1.4 billion in Q2 2025.
• Historically, Cash from Investing Activities has averaged -$254.3 million across 5 years, with a median of -$165.6 million in 2023.
• Biggest YoY gain for Cash from Investing Activities was 45.64% in 2025; the steepest drop was 460.49% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at -$112.5 million in 2022, then plunged by 96.27% to -$220.8 million in 2023, then plunged by 31.88% to -$291.2 million in 2024, then retreated by 10.58% to -$322.0 million in 2025, then jumped by 50.62% to -$159.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$159.0 million (Q1 2026), -$322.0 million (Q4 2025), and -$163.3 million (Q3 2025), per Business Quant data.